Medipattern's B-CAD(R) Increases Diagnostic Accuracy On Small Breast Cancer Lesions B
 

The Medipattern Corporation (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that a study abstract, showing a statistically significant increase in diagnostic accuracy when using B-CAD Version 2 on lesions less than 1 cm in size, has been published in the October 2008 issue of the American Journal of Clinical Oncology.

More...